Effect size of rituximab on pulmonary function in the treatment of connective-tissue disease-related interstitial lung disease: a systematic review and meta-analysis

Abstract Background Rituximab (RTX) has been previously reported as directed treatment in patients with connective-tissue disease-related interstitial lung diseases (CTD-ILD). A systematic assessment of treatment effect size on pulmonary function outcomes and related adverse effects in patients with...

Full description

Bibliographic Details
Main Authors: Yuanchen Zhao, Yang Gao, Tananchai Petnak, Wisit Cheungpasitporn, Charat Thongprayoon, Xing Zhang, Teng Moua
Format: Article
Language:English
Published: BMC 2022-06-01
Series:Respiratory Research
Subjects:
Online Access:https://doi.org/10.1186/s12931-022-02082-x

Similar Items